Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5645-5650

  Kenerson, Heidi L ^a   Aicher, Lauri D ^a   True, Lawrence D ^a   Yeung, Raymond S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; CYCLIN D1; GENE PRODUCT; INITIATION FACTOR 4G; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P27; PROTEIN TSC1; RAPAMYCIN; S6 KINASE; TUBERIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; IN VIVO STUDY; KIDNEY TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; GERM-LINE MUTATION; KIDNEY NEOPLASMS; MALE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RATS; RATS, INBRED F344; REPRESSOR PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037108682     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gomez, M. R. Tuberous Sclerosis, 3rd Ed., pp. 10-23. New York: Oxford University Press, 1999.
2. Montagne, J., Radimerski, T., and Thomas, G. Insulin signaling: Lessons from the Drosophila tuberous sclerosis complex, a tumor suppressor. Sci. STKE, 105: PE36, 2001.
3. Manning, B., Tee, A., Logsdon, M., Blenis, J., and Cantley, L. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway. Mol. Cell, 10: 151-162, 2002.
4. Dan, H., Sun, M., Yang, L., Feldman, R., Sui, X., Yeung, R., Halley, D., Nicosia, S., Pledger, W., and Cheng, J. PI3K/AKT pathway regulates TSC tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem., 277: 35364-35370, 2002.
5. Aicher, L. D., Campbell, J. S., and Yeung, R. S. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J. Biol. Chem., 276: 21017-21021, 2001.
6. Hengstschlager, M., Rodman, D. M., Miloloza, A., Hengstschlager-Otmad, E., Rosner, M., and Kubista, M. Tuberous sclerosis gene products in proliferation control. Mutat. Res., 488: 233-239, 2001.
7. Templeton, D. J. Protein kinases: Getting NEKed for S6K activation. Curr. Biol., 11: R596-R599, 2001.
8. Rohde, J., Heitman, J., and Cardenas, M. E. The TOR kinases link nutrient sensing to cell growth. J. Biol. Chem., 276: 9583-9586, 2001.
9. Barlund, M., Forozan, F., Kononen, J., Bubendorf, L., Chen, Y., Bittner, M. L., Tothorst, J., Haas, P., Bucher, C., Sauter, G., Kallioniemi, O. P., and Kallioniemi, A. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J. Natl. Cancer Inst. (Bethesda), 92: 1252-1259, 2000.
10. Heitman, J., Movva, N. R., and Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (Wash. DC), 253: 905-909, 1991.
11. Yeung, R. S., Xiao, G. H., Jin, F., Lee, W. C., Testa, J. R., and Knudson, A. G. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl. Acad. Sci. USA, 91: 11413-11416, 1994.
12. Reynolds, T. H., Bodine, S. C., and Lawrence, J. C., Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem., 277: 17657-17662, 2002.
13. Johanson, S. O., Naccache, P. A., and Crouch, M. F. A p85 subunit-independent p110α PI 3-kinase colocalizes with p70 S6 kinase on actin stress fibers and regulates thrombin-stimulated stress fiber formation in Swiss 3T3 cells. Exp. Cell Res., 248: 223-233, 1999.
14. Zhang, X., Shu, L., Hosoi, H., Murti, K. G., and Houghton, P. J. Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J. Biol. Chem., 277: 28127-28134, 2002.
15. Kondo, K., and Kaelin, W. G., Jr. The von Hippel-Lindau tumor suppressor gene. Exp. Cell Res., 264: 117-125, 2001.
16. Smolarek, T., A., Wessner, L. L., McCormack, F. X., Mylet, J. C., Menon, A. G., and Henske, E. P. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am. J. Hum. Genet., 62: 810-815, 1998.
17. Kajino, K., and Hino, O. TSC1 and TSC2 gene mutations in human kidney tumors. Contrib. Nephrol., 128, 45-50, 1999.
18. Kwiatkowski, D. J., Zhang, H., Bandura, J. L., Heiberger, K. M., Glogauer, M., el-Hashemite, N., and Onda, H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet., 11: 525-534, 2002.
19. Goncharova, E. A., Goncharov, D. A., Eszterhas, A., Hunter, D. S., Glassberg, M. K., Yeung, R. S., Walker, C. L., Noonan, D., Kwiatkowski, D. J., Chou, M. M., Panettieri, R. A., Jr., and Krymskaya, V. P. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem., 277: 30958-30967, 2002.
20. Onda, H., Lueck, A., Marks, P. W., Warren, H. B., and Kwiatkowski, D. J. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Investig., 104: 687-695, 1999.
21. Harada, H., Andersen, J. S., Mann, M., Terada, N., and Korsmeyer, S. J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl. Acad. Sci. USA, 98: 9666-9670, 2001.
22. Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., and Rosen, N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem., 273: 29864-29872, 1998.
23. Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., and Battegay, E. J. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J., 16: 771-780, 2002.
24. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., and Van Obberghen, E. Insulin stimulates HIF-1 through a PI-3-kinase/TOR-dependent pathway. J. Biol. Chem., 277: 27975-27981, 2002.
25. Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., Jauch, K. W., and Geissler, E. K. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat. Med., 8: 128-135, 2002.
26. Sekulic, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Kamitz, L. M., and Abraham, R. T. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res., 60: 3504-3513, 2000.
27. Gingras, A. C., Kennedy, S. G., O'Leary, M. A., Sonenberg, N., and Hay, N. 4E-BPI, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev., 12: 502-513, 1998.
28. Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell. Biol., 4: 648-657, 2002.